Discussion
Blocking the activity of a protein called BACH2 may be a valuable strategy for treating sickle cell disease (SCD) and related blood disorders, a study shows. Researchers found that suppressing BACH2 could increase the production of fetal hemoglobin (HbF). Increasing HbF levels is an established approach for SCD…